News

Pfizer's innovative business should grow faster after it divests its off-patent division Upjohn in 2020 to create Viatris and ...
Pfizer Inc. (NYSE:PFE) is navigating a period of strategic upheaval and legal scrutiny as it ends its clinical collaboration ...
Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...
Pfizer Inc. has secured an exclusive global licensing agreement with 3SBio, Inc., a leading Chinese biopharma, for SSGJ-707.
The Sport Impact Summit (SIS) has announced two major strategic partnerships with Scoreboard, sport’s leading AI-powered ...
BIOSeedin Innovation Partnering Conference solidified its role as a nexus for global biopharma innovation, attracting more than 2,000 registrants from 10 countries. Senior executives and investors ...
Seongnam: SK bioscience, a global vaccine and biotech company, has announced that the Supreme Court of Korea has ruled in its favor in a patent infringement lawsuit filed by large ...
The global CRISPR technology market is expected to witness a growth rate of 16% in the next five years. Continuous ...
The two platforms offer public and private sector organisations ready-to-deploy tools for both reporting and storytelling — ...
Amitesh Rao, CEO of Leo South Asia, defines success as daily reinvention, driven by strategic depth, capability expansion, ...